Peptide Directory

A synthetic peptide derived from a protective protein found in gastric juice, widely discussed for tissue repair and recovery.

A GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management, one of the most widely prescribed peptide drugs.

A dual GIP/GLP-1 receptor agonist FDA-approved for diabetes and weight management, producing the largest weight loss seen in clinical trials.

A growth hormone-releasing hormone analog that stimulates the pituitary gland to produce more growth hormone.

A selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin.

Precursors to NAD+, a critical coenzyme for cellular energy and longevity pathways. NAD+ levels decline with age.

A synthetic version of the active region of thymosin beta-4, widely used for tissue repair, wound healing, and recovery from injuries.

A naturally occurring copper-binding peptide with extensive research on skin remodeling, wound healing, and anti-aging.

An investigational triple agonist (GIP/GLP-1/glucagon) that produced 24% weight loss in Phase II trials, potentially the most effective obesity drug.

A naturally occurring neuropeptide involved in social bonding, trust, and reproduction, FDA-approved for labor induction.

The body's most abundant antioxidant, a tripeptide critical for detoxification, immune function, and cellular protection.

A synthetic peptide analog of ACTH(4-10) developed in Russia, studied for cognitive enhancement and neuroprotection.

A growth hormone-releasing hormone analog that was previously FDA-approved for diagnosing GH deficiency in children.

An orally active growth hormone secretagogue that mimics ghrelin to stimulate GH and IGF-1 release.

An FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder in premenopausal women, also studied for broader sexual dysfunction.

A stabilized form of BPC-157 combined with arginine, offering enhanced stability and potentially improved oral bioavailability.

A modified growth hormone releasing hormone analog with a shorter half-life than DAC-conjugated CJC-1295, allowing more physiological GH pulsing.

A GLP-1 receptor agonist FDA-approved for diabetes (Victoza) and weight management (Saxenda), the predecessor to semaglutide.

A naturally occurring protein that inhibits myostatin (the muscle growth limiter), studied for dramatic muscle growth potential.

A tripeptide fragment of alpha-MSH with potent anti-inflammatory properties, studied for inflammatory bowel disease and skin conditions.

A cosmetic peptide that reduces wrinkles by inhibiting neurotransmitter release at the neuromuscular junction, often called 'topical Botox.'

A collagen-stimulating cosmetic peptide that signals skin to produce more collagen and extracellular matrix proteins.

A long-acting amylin analogue being developed in combination with semaglutide (CagriSema) for enhanced weight loss.

A synthetic peptide analog of tuftsin with anxiolytic and nootropic properties, developed in Russia.

An FDA-approved GHRH analog used to reduce visceral fat in HIV-associated lipodystrophy.

A modified fragment of human growth hormone studied specifically for fat metabolism without the growth-promoting effects of full GH.

A senolytic peptide designed to selectively clear senescent cells by disrupting the FOXO4-p53 interaction, studied for anti-aging applications.

A porcine brain-derived peptide preparation with neurotrophic properties, approved in several countries for stroke recovery and cognitive disorders.

A synthetic growth hormone secretagogue that stimulates natural GH release, studied for body composition, recovery, and anti-aging.

A potent growth hormone secretagogue peptide that also has cardioprotective properties independent of GH release.

A modified version of IGF-1 with extended half-life and reduced IGF binding protein affinity, used for muscle growth.

An enhanced version of Selank with improved stability, studied for anxiety reduction and cognitive enhancement.

Synthetic gonadotropin-releasing hormone used diagnostically and therapeutically for reproductive hormone assessment and fertility.

A synthetic melanocortin peptide studied for tanning, sexual function, and appetite suppression. Not FDA-approved; the FDA has issued public warnings against its use.

A synthetic tetrapeptide studied for its potential to activate telomerase and influence cellular aging.

A thymic peptide approved in multiple countries for immune modulation, particularly in hepatitis and as a vaccine adjuvant.

A mitochondria-derived peptide with cytoprotective properties, studied for neuroprotection, metabolic regulation, and anti-aging effects.

A naturally occurring neuropeptide with anti-inflammatory, neuroprotective, and immune-modulating properties. Early clinical data exists for pulmonary hypertension; other therapeutic uses remain under investigation.

A synthetic growth hormone secretagogue known for potent GH release and significant appetite stimulation through ghrelin receptor activation.

A synthetic peptide that regulates intestinal tight junctions, in clinical trials for celiac disease and studied for leaky gut conditions.

The first GLP-1 receptor agonist, originally derived from Gila monster venom, FDA-approved for type 2 diabetes.

A truncated form of IGF-1 missing the first 3 amino acids, with 10x greater potency and very short half-life for localized effects.

A splice variant of IGF-1 produced in response to mechanical stress on muscles, promoting satellite cell activation and muscle repair.

A PEGylated version of MGF with extended half-life for systemic muscle growth and recovery effects.

An FDA-approved fragment of parathyroid hormone that stimulates new bone formation, used for severe osteoporosis.

A neuropeptide that regulates wakefulness, arousal, and appetite. Its deficiency causes narcolepsy.

A CNTF-derived peptide that promotes neurogenesis and has shown promise in Alzheimer's disease research.

An FDA-approved GnRH agonist used for prostate cancer, endometriosis, and precocious puberty through hormonal suppression.

A naturally occurring peptide hormone that raises blood sugar, FDA-approved as emergency treatment for severe hypoglycemia.

An enhanced version of Epithalon with improved stability, studied for telomerase activation, pineal gland regulation, and anti-aging effects.

An FDA-approved selective MC1R agonist for erythropoietic protoporphyria (EPP). Stimulates protective eumelanin production without the broad side effects of Melanotan II.

A naturally occurring antimicrobial peptide that plays a key role in innate immune defense.

A potent angiotensin IV analog studied for cognitive enhancement and potential treatment of neurodegenerative conditions.

A naturally occurring neuropeptide that modulates sleep patterns and has been studied for insomnia and stress.

A cosmetic peptide that reduces the appearance of wrinkles by modulating neuromuscular junction signaling.

A mitochondria-derived peptide that regulates metabolic homeostasis and has been called an 'exercise mimetic.'

A thymic peptide complex studied for immune system restoration, particularly in aging populations and immunocompromised states.

A synthetic peptide derived from sortilin that acts as a TREK-1 channel blocker, studied as a rapid-acting antidepressant alternative.

An FDA-approved peptide hormone used to treat osteoporosis and Paget's disease by inhibiting bone resorption.

A synthetic analogue of vasopressin (ADH) FDA-approved for diabetes insipidus, bedwetting, and bleeding disorders.

An FDA-approved synthetic analogue of amylin used alongside insulin for diabetes, also studied for weight management.

An FDA-approved MC4R agonist for rare genetic obesity disorders, representing a precision medicine approach to weight management.

An FDA-approved somatostatin analogue used to treat acromegaly, carcinoid tumors, and severe diarrhea.

An FDA-approved immunomodulatory peptide mixture for relapsing-remitting multiple sclerosis (MS).

A semi-synthetic polysaccharide with FDA approval for interstitial cystitis, also studied for joint and cartilage health.

A chemically modified version of Semax designed for improved stability. No published clinical or preclinical data exists for this specific compound.

A naturally occurring neuropeptide that plays a central role in reproductive hormone regulation and fertility.

A mitochondria-targeted peptide in clinical trials for heart failure and mitochondrial diseases.

A short tripeptide studied for neuroprotective and cognitive-enhancing properties, part of the Khavinson peptide bioregulator family.

A zinc-dependent thymic peptide involved in T-cell maturation, studied for immune restoration and anti-inflammatory applications.

A synthetic peptide bioregulator targeting brain cortex function, studied for cognitive enhancement and neuroprotection in aging.

An FDA-approved peripheral kappa opioid receptor agonist for chronic kidney disease-associated itch, without CNS side effects.

An FDA-approved GLP-2 analogue that promotes intestinal growth, used for short bowel syndrome.

The first FDA-approved treatment for Rett syndrome, a synthetic analogue of a naturally occurring IGF-1 tripeptide fragment.